These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17425843)

  • 1. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
    Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
    Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.
    Xue LY; Hu N; Song YM; Zou SM; Shou JZ; Qian LX; Ren LQ; Lin DM; Tong T; He ZG; Zhan QM; Taylor PR; Lu N
    BMC Cancer; 2006 Dec; 6():296. PubMed ID: 17187659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray.
    Gomes TS; Oshima CT; Segreto HR; Barrazueta LM; Costa HO; Lima FO; Forones NM; Ribeiro DA
    Pathol Res Pract; 2011 Oct; 207(10):613-7. PubMed ID: 21856093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma.
    Takikita M; Hu N; Shou JZ; Wang QH; Giffen C; Taylor PR; Hewitt SM
    BMC Cancer; 2009 Sep; 9():310. PubMed ID: 19728877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
    Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
    Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
    Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
    Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan.
    Wang LS; Chow KC; Wu YC; Li WY; Huang MH
    Am J Gastroenterol; 1999 Oct; 94(10):2834-9. PubMed ID: 10520830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
    Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
    Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
    Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
    Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of Fas and FasL protein in squamous cell carcinoma of larynx].
    Shi L; Li G; Zhu C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 16(12):661-2. PubMed ID: 12669436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma.
    Fan S; Müller S; Chen ZG; Pan L; Tighiouart M; Shin DM; Khuri FR; Sun SY
    Cancer Biol Ther; 2013 Apr; 14(4):365-9. PubMed ID: 23358467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.
    Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY
    Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.
    Li Y; Xu KP; Jiang D; Zhao J; Ge JF; Zheng SY
    Int J Clin Exp Pathol; 2015; 8(11):13978-86. PubMed ID: 26823709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.